SYNENDOS
Live / Registered — Registered (as of 22 Aug 2023)
What this means for you
Registered since 22 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79330074
- Registration number
- 7141186
- Mark type
- Stylized text
- Filed
- 10 Nov 2021
- Published for opposition
- 06 Jun 2023
- Registered
- 22 Aug 2023
- Attorney of record
- Catherine F. Hoffman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; medical preparations and substances for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; medical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; veterinary preparations and substances for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; sanitary preparations for medical use; medicines for pharmaceutical use for the treatment of neuropsychiatric, neurological and psychiatric diseases and disorders; medicines for pharmaceutical use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; medicines for human medicine for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, renal, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, inflammatory, immune, autoimmune, and genetic diseases and disorders; medicines for human medicine, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; medicines for human medicine, namely, medicines for treating biochemical imbalances in vivo; chemical-pharmaceutical preparations, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; chemical preparations for medical use, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; chemical preparations for pharmaceutical use, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; chemical preparations for veterinary use, namely, pharmaceutical preparations acting on the central nervous system, biopharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting the peripheral nervous system and biopharmaceutical agents affecting the peripheral nervous system; chemical preparations for medical use for treating biochemical imbalances in vivo; chemical preparations for veterinary use for treating biochemical imbalances in vivo; diagnostic substances, preparations and agents for medical use
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis, testing in the fields of pharmaceuticals, biopharmaceuticals, chemistry, biology, biochemistry; industrial analysis services, namely, industrial analysis in the fields of pharmaceuticals, biopharmaceuticals; industrial research services in the fields of pharmaceuticals, biopharmaceuticals; scientific research and development; scientific research; scientific analysis, namely, biological analysis, biochemical analysis, chemical analysis; conducting chemical and biological analyses for scientific purposes; conducting medical analysis for scientific purposes, namely, biological analysis, biochemical analysis, chemical analysis, blood analysis; medical research; pharmaceutical research; research in the fields of chemistry and biology; biotechnological research services; providing medical and scientific research information, namely, providing information and data with respect to medical and veterinary research and development; providing information with respect to medical and scientific research in the field of pharmaceutical products; providing scientific information on research in the field of pharmaceutical products and biomedicine
- Class 044 — Medical, beauty and agricultural services: Medical services; veterinary services; hygienic care for human beings; medical and pharmaceutical consultancy services; medical tests for diagnostic or treatment purposes; conducting of medical examinations; consultations regarding pharmacology; pharmaceutical consulting, namely, consultant and information services relating to pharmaceutical products; conducting of chemical, medical and biological analyses for medical diagnosis being medical diagnostic testing services; consultancy and information services relating to medical products being pharmaceutical consultation services; medical analysis services relating to the treatment of patients; medical consultancy services; pharmacy advice being pharmaceutical consultation
Owner
Prosecution history
- 26 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Dec 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Nov 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Nov 2023 — FINAL DISPOSITION PROCESSED
- 22 Nov 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 19 Jun 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 06 Jun 2023 — NOTIFICATION PROCESSED BY IB
- 06 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jun 2023 — PUBLISHED FOR OPPOSITION